Calcium channel modulation by dihydropyridines modifies sufentanil-induced antinociception in acute and tolerant conditions
- 1 November 1990
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 342 (5) , 559-565
- https://doi.org/10.1007/bf00169046
Abstract
The study was aimed at elucidating the possible participation of l-type Ca2+ channel in the acute analgesic effect of an opiate and the development of tolerance to this action. Sufentanil, a selective p agonist, and two dihydropyridines, the Ca2+ antagonist nimodipine and the Ca2+ agonist Bay K 8644, were selected. The tail-flick test was used to assess the nociceptive threshold. In naive rats, nimodipine (200 μg/kg) potentiated the analgesic effect of sufentanil reducing the ED50 from 0.26 to 0.08 μg/kg. Similar results were observed with its (−)-enantiomer Bay N 5248, while the (+) enantiomer Bay N 5247 was ineffective. Tolerance to the opiate was induced by chronic subcutaneous administration of sufentanil with minipumps (2 μg/h, 7 days). In these conditions the dose-response curve to sufentanil was displaced to the right and the ED50 was increased to 1.49 μg/kg. In tolerant rats, nimodipine preserved its potentiating ability and prevented the displacement to the right of the sufentanil dose response-curve (ED50 = 0.48 μg/kg). When nimodipine was pumped (1 μg/h, 7 days) concurrently with sufentanil, the development of tolerance to the opioid was not disturbed. However, the expression of tolerance was abolished and even the effect of acutely administered sufentanil was markedly potentiated (ED50 = 0.03 μg/kg). Similar experiments were performed with Bay K 8644. In naive rats, Bay K 8644 at a low dose (20 μg/kg) that behaves as a calcium agonist, antagonized the analgesic effect of sufentanil (ED50 = 0.58 μg/kg), whereas at a high dose (200 μg/kg) it potentiated this action (ED50 = 0.15 μg/kg). In tolerant rats, Bay K 8644 (20 μg/kg) preserved its antagonizing ability inducing a displacement to the right of the sufentanildose-response curve (ED50 = 4.2 μg/kg). When Bay K 8644 was pumped (1 μg/h, 7 days) concurrently with sufentanil, it enhanced the expression of tolerance to the opiate (ED50 = 3.8 μg/kg). These results suggest that the calcium fluxes through the l-type channel in neurones are functionally linked to the activation of the μ opiate receptor: the blockade of the channel increased the potency of sufentanil, whereas its activation reduced the potency of the opiate. In chronic experiments, DHPs concurrently administered with sufentanil did not affect the development of tolerance to the opiate. However, nimodipine prevented the expression of this phenomenon. Even more, the animals became hypersensitive to the opiate suggesting that the adaptative mechanisms induced by chronic opiate could be affected by chronic nimodipine.Keywords
This publication has 38 references indexed in Scilit:
- Noradrenaline‐ and Enkephalin‐Induced Inhibition of Voltage‐Sensitive Calcium Currents in NG108‐15 Hybrid CellsEuropean Journal of Neuroscience, 1989
- Central and peripheral effects of the dihydropyridine calcium channel activator BAY K 8644 in the ratEuropean Journal of Pharmacology, 1989
- The effect of κ agonist U50-488H on [3H]nimodipine receptor binding in rat brain regionsEuropean Journal of Pharmacology, 1988
- Prolonged morphine treatment increases rat brain dihydropyridine binding sites: possible involvement in development of morphine dependenceEuropean Journal of Pharmacology, 1988
- Multiple Calcium Channels and Neuronal FunctionScience, 1987
- Opioid peptides selective for mu- and delta-opiate receptors reduce calcium-dependent action potential duration by increasing potassium conductanceNeuroscience Letters, 1983
- Morphine inhibits depolarization-dependent calcium uptake by synaptosomesEuropean Journal of Pharmacology, 1983
- Radioimmunoassay of the new opiate analgesics alfentanil and sufentanil. Preliminary pharmacokinetic profile in manJournal of Pharmacy and Pharmacology, 1983
- Opioids/opiates analgesic response modified by calciumLife Sciences, 1982
- Discrete changes in brain calcium with morphine analgesia, tolerance-dependence, and abstinenceLife Sciences, 1977